BIOXYTRAN, INC Quarterly Return On Equity in % from Q3 2018 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Bioxytran, Inc quarterly/annual Return On Equity history and growth rate from Q3 2018 to Q3 2024.
  • Bioxytran, Inc Return On Equity for the quarter ending September 30, 2024 was 191 %, a 40.4% increase year-over-year.
  • Bioxytran, Inc annual Return On Equity for 2023 was 149 %, a 122% increase from 2022.
  • Bioxytran, Inc annual Return On Equity for 2022 was 67.4 %, a 62.9% decline from 2021.
  • Bioxytran, Inc annual Return On Equity for 2021 was 182 %.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 191 +55.1 +40.4% Jul 1, 2024 Sep 30, 2024
Q2 2024 202 +101 +100% Apr 1, 2024 Jun 30, 2024
Q1 2024 202 +138 +215% Jan 1, 2024 Mar 31, 2024
Q4 2023 149 +82.1 +122% Oct 1, 2023 Dec 31, 2023
Q3 2023 136 +62 +83.6% Jul 1, 2023 Sep 30, 2023
Q2 2023 101 +13.3 +15.2% Apr 1, 2023 Jun 30, 2023
Q1 2023 64 -63.1 -49.6% Jan 1, 2023 Mar 31, 2023
Q4 2022 67.4 -114 -62.9% Oct 1, 2022 Dec 31, 2022
Q3 2022 74.1 -128 -63.3% Jul 1, 2022 Sep 30, 2022
Q2 2022 87.6 Apr 1, 2022 Jun 30, 2022
Q1 2022 127 Jan 1, 2022 Mar 31, 2022
Q4 2021 182 Oct 1, 2021 Dec 31, 2021
Q3 2021 202 Jul 1, 2021 Sep 30, 2021
Q4 2019 226 -200 -47% Oct 1, 2019 Dec 31, 2019
Q3 2019 114 -5.8K -98.1% Jul 1, 2019 Sep 30, 2019
Q2 2019 -13.2 Apr 1, 2019 Jun 30, 2019
Q1 2019 -78.2 Jan 1, 2019 Mar 31, 2019
Q4 2018 426 Oct 1, 2018 Dec 31, 2018
Q3 2018 5.92K Jul 1, 2018 Sep 30, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.